EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
August 02 2022 - 7:00AM
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical
company committed to developing and commercializing therapeutics to
improve the lives of patients with serious eye disorders, today
announced that EyePoint Pharmaceuticals’ will present at the
following upcoming conferences:
- BTIG Biotechnology
Conference
Forum: Panel Date: Tuesday, August 9, 2022Time:
10:00 a.m. ET
- H.C. Wainwright 2nd Annual
Ophthalmology Virtual Conference
Forum: Corporate Presentation / PanelDate:
Wednesday, August 17, 2022 Time: 7:00 a.m. ET / 11:00 a.m. ET
A webcast and subsequent archived replay of the
H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
corporate presentation and panel may be accessed via the Investors
section of the Company website at www.eyepointpharma.com. The
replay will be available for 90 days after the event. The live
webcast of the BTIG panel will be available on BTIG’s conference
website at the time of the event, and a replay will be available
through BTIG’s research access.
About EyePoint
Pharmaceuticals
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a
pharmaceutical company committed to developing and commercializing
therapeutics to help improve the lives of patients with serious eye
disorders. The Company's pipeline leverages its proprietary
Durasert® technology for sustained intraocular drug delivery
including EYP-1901, an investigational sustained delivery
intravitreal anti-VEGF treatment initially targeting wet
age-related macular degeneration. The proven Durasert drug delivery
platform has been safely administered to thousands of patients'
eyes across four U.S. FDA approved products, including YUTIQ® for
the treatment of chronic non-infectious uveitis affecting the
posterior segment of the eye, which is currently marketed by the
Company. EyePoint Pharmaceuticals is headquartered in Watertown,
Massachusetts.
Investors:
Christina TartagliaStern IRDirect:
212-698-8700christina.tartaglia@sternir.com
Media Contact
Amy PhillipsGreen Room CommunicationsDirect:
412-327-9499aphillips@greenroompr.com
EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Sep 2023 to Sep 2024